X

PFE

Pfizer inc (PFE) Sec Form 10K

Pfizer inc (NYSE: PFE) Sec Form 10K

Pfizer inc (PFE) PADCEV + Keytruda Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Pfizer inc (NYSE: PFE) FY 2026 Other Release

Pfizer inc (PFE) U.S. FDA Grants Full Approval to Pfizer’s BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer inc (NYSE: PFE) FY 2026 Other Release

Pfizer inc (PFE) Pfizer Discussion at Healthcare Conference

Pfizer inc (NYSE: PFE) FY 2026 Corporate Conference

Pfizer inc (PFE) Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Pfizer inc (NYSE: PFE) FY 2026 Other Release

Key highlights from Pfizer’s (PFE) Q4 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2025 earnings results today. Revenues dipped 1% year-over-year to $17.6 billion. On…

Pfizer inc (PFE) Q2 2025 Earnings Call Transcript

Pfizer inc (NYSE: PFE) Q2 2025 Earnings Call dated Aug. 05, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations…

Pfizer inc (PFE) Q3 2025 Earnings Call Transcript

Pfizer inc (NYSE: PFE) Q3 2025 Earnings Call dated Nov. 04, 2025 Corporate Participants: Francesca DeMartino — Chief Investor Relations…

Key takeaways from Pfizer’s (PFE) Q3 2025 earnings report

Shares of Pfizer Inc. (NYSE: PFE) stayed green during midday trade on Tuesday following the company’s announcement of its third…

Key highlights from Pfizer’s (PFE) Q1 2025 earnings results

Pfizer Inc. (NYSE: PFE) reported its first quarter 2025 earnings results today. Revenues decreased 8% year-over-year to $13.7 billion. GAAP…